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Detailed understanding of the epidemiology of
Campylobacter is increasingly facilitated through use of
universal and reproducible techniques for accurate strain
differentiation and subtyping. Multilocus sequence typing
(MLST) enables discriminatory subtyping and grouping of
isolate types into genetically related clonal complexes; it
also has the advantage of ease of application and repeata-
bility. Recent studies suggest that a measure of host asso-
ciation may be distinguishable with this system. We
describe the first continuous population-based survey to
investigate the potential of MLST to resolve questions of
campylobacteriosis epidemiology. We demonstrate the
ability of MLST to identify variations in the epidemiology of
campylobacteriosis between distinct populations and
describe the distribution of key subtypes of interest. 
C
ampylobacter has been the most commonly reported
bacterial enteric pathogen causing gastrointestinal ill-
ness in England and Wales for at least the last 15 years (1).
The main species infecting humans are Campylobacter
jejuni and C. coli; these species also colonize many differ-
ent animals, especially birds (2).
In Europe, campylobacteriosis shows a marked season-
ality with a peak during the summer months (3,4),
although this pattern is more marked in some countries
than others (5). Especially sharp and annually consistent
rises in incidence are reported in the United Kingdom,
Greece, the Netherlands, and Denmark (5). A study in
northwest (NW) England also indicated a consistent peak
of human infection in March (6). Some studies have shown
a coincident seasonality of infection in broiler chickens
and humans in Scandinavia and contamination of retail
raw chicken and infection in humans in the United
Kingdom and suggest a common environmental trigger
(2,7,8). In a recent study of the influence of rainfall, sun-
shine, and temperature on seasonality in different regions
of England and Wales, increasing incidence of campy-
lobacteriosis was most strongly correlated with increases
in air temperature (9).
Studies in northern Europe have attempted to identify
environmental reservoirs of infection in water sources and
livestock that could explain the seasonality of human
infection. These studies have demonstrated campylobacter
carriage rates peaking in late spring and summer in broiler
chicken flocks (10,11) and dairy cattle (12) but more con-
stant infection in lambs and beef cattle (12,13).
Campylobacter has been successfully isolated and cultured
from surface water in Finland (14,15), Italy (16), and NW
England (17), and sporadic campylobacteriosis (illness not
associated with an outbreak) has been linked with expo-
sure to untreated water in Scandinavia (18,19). C. jejuni
has also been isolated from a wide range of animal and
environmental samples in a rural area in NW England,
which suggests a potential environmental risk for exposure
(20).
Molecular subtyping methods including pulsed-field
gel electrophoresis (PFGE) (21), fluorescent amplified
fragment length polymorphisms (22), and multilocus
sequence typing (MLST) (23) have been applied to C. jeju-
ni to overcome the problems associated with traditional
phenotypic methods. Although PFGE has been accurately
and reproducibly used for several years to investigate dis-
ease clusters (24), an advantage of MLST is its ability to
sequence isolate types and thus group them into genetical-
ly related clonal complexes; this is especially useful for
integrating newly identified sequence types. MLST has
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Previous studies that used phenotypic strain characteriza-
tion methods failed to establish source/host associations
for particular phenotypes (26), but recent studies with
MLST, including a study in NW England, suggest that a
measure of host association may be distinguishable when
this system is used (27).
No continuous population-based survey has been per-
formed to investigate the potential of MLST to answer the
unresolved questions of campylobacteriosis epidemiology,
particularly the drivers of the seasonal peak in the United
Kingdom. This article is the first report of a 3-year study
that used MLST to investigate campylobacteriosis in NW
England in 2 defined human populations, 1 small
town–based and rural  and l metropolitan and suburban.
Methods
Study Population
The study population was defined as all persons with
confirmed Campylobacter from April 2003 to March 2004
reported by residents in 4 local authorities (government
administrative boundaries) in NW England (Figure 1).
Wyre (population 106,826) and Fylde (74,032) local
authorities adjoin geographically in the county of
Lancashire and largely consist of rural and small
town–based populations. For the purposes of this study,
this area is referred to as rural. Salford (216,178) and
Trafford (209,760) local authorities also adjoin geographi-
cally within the conurbation of Greater Manchester and are
predominantly a mix of metropolitan and suburban dis-
tricts. This area is referred to as suburban in this study. The
2 areas are ≈50 km apart and share some of the same drink-
ing water sources but are environmentally located in dif-
ferent water catchment areas.
Data Collection
Confirmed cases of campylobacteriosis (according to
the UK National Standard Method for diagnosis [28]) are
routinely reported to the NW Health Protection Agency
(HPA) surveillance system by local National Health
Service laboratories. Case-patients were identified as resi-
dents in the study area through available geographic infor-
mation or by patient names, when geographic information
was not available. Reports included basic demographic
information such as age, sex, and date of disease onset.
Where date of onset was not available, date of report was
used as a proxy. Travel overseas was not well recorded in
these data.
Positive isolates of Campylobacter from patients resi-
dent in the study area were sent by the main diagnostic lab-
oratories to the NW HPA Laboratory in Manchester for
sequence typing. Case-patients were determined to be res-
idents in the study area by using the methods described
above.
Campylobacter Speciation
C. jejuni isolates were spread onto Colombia blood
agar (Oxoid CM331, Unipath, UK) containing 5% defibri-
nated horse blood and incubated at 37°C in anaerobic jars
(Don Whitley Scientific, Shipley, UK) under microaerobic
conditions (5% CO2, 5% O2, 3% H2, 87% N2). DNA was
extracted (10% dilutions) and tested for C. jejuni or C. coli
by using a previously described Taqman assay (29) with
primers and probes for the genes ceuE (for C. coli) and
mapA (for C. jejuni).
Sequence Typing of C. jejuni Isolates
MLST was performed as described (23). The amplifica-
tion reactions were performed in a 50-µL volume contain-
ing ≈1 µL C. jejuni chromosomal DNA (10 ng/µL), 5 µL
of each primer (10 pmol/µL), 10 µLof 1 mmol/Ldeoxynu-
cleoside triphosphates (Roche, Welwyn Garden City, UK),
5 µL1 0 × PCR buffer (Qiagen, Crawley, UK), and 0.25 U
Taq DNA polymerase (Qiagen). The thermal cycling con-
ditions were as follows: initial denaturation at 94°C for 5
min, 40 cycles of denaturation at 94°C for 2 min; primer
annealing at 50°C for 1 min; and extension at 72°C for
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Figure 1. Location of the 4 local authorities constituting the study
area in Northwest England. The populations covered (outlined
areas) were Fylde and Wyre (in Lancashire) and Salford and
Trafford (within the metropolitan area of Greater Manchester).
Gray areas indicate approximate location of built-up areas.1 min with a final elongation step at 72°C for 10 min.
Thermal cycling was conducted with an MJ PTC 200 ther-
mal cycler. Amplicons were detected on a 1.5% ethidium
bromide agarose gel and purified by using a UniFilter
Multiscreen PCR cleanup plate (Whatman, Brentford, UK)
according to the manufacturer’s instructions. Sequencing
reactions were conducted in 10 µLof 1/4 reaction volumes
containing 2 µL purified DNA, 0.5 µL primer (10
pmol/µL), 1 µL sequencing buffer (Genetix, New Milton,
UK), 2 µL DTCS Quick Start Master Mix (Beckman
Coulter, Fullerton, CA, USA), and 4.5 µL molecular grade
water. Thermal cycling conditions for sequencing reac-
tions and ethanol cleanup of sequenced products were set
up according to the manufacturer’s instructions (Beckman
Coulter). The products were analyzed on a Beckman
Coulter CEQ 8000 automated DNA sequencer (Beckman
Coulter). All sequence assemblage and editing were per-
formed with Sequencher 4.0 software (GeneCodes
Corporation, Ann Arbor, MI, USA).
MLST Allele and ST Assignment
MLST alleles, sequence types (STs), and clonal com-
plexes were assigned by using the Campylobacter
PubMLST database (30). Sequences were submitted for
allele designation as appropriate.
Statistical Analysis
Incidence rates quoted were calculated per 100,000
population by using the relevant 2003 annual population
estimate for each local authority area, purchased from the
UK Office for National Statistics. Incidence ratios, associ-
ated 95% confidence intervals (CIs), and p values were
calculated by using StatsDirect statistical software
(http://www.statsdirect.com/), which used Fisher exact test
to analyze the difference between 2 crude rates. A mid-p
approach to Fisher exact test was also used to test the sig-
nificance of observed differences in proportions (by using
StatsDirect). The level of statistical significance chosen for
all analyses was p<0.05.
Results
Seasonal Incidence of Reported Disease
During the first 12 months of the study period (April
2003–March 2004), 493 cases of laboratory-confirmed
Campylobacter sp. were reported through the NW surveil-
lance system (Table 1) from residents of Fylde, Wyre,
Salford, and Trafford local authorities (Figure 1). This cor-
responded to approximate annual incidences of
100/100,000 for the area encompassing Fylde and Wyre
(rural area) and 73.3/100,000 for the area encompassing
Salford and Trafford (suburban area); this difference was
significant (p<0.001). The incidence for the whole region
of NW England in this period was 69.8/100,000 (data not
shown). A similar seasonal pattern of cases was seen in
each of the 2 areas in the study, with a large increase in
reported cases between weeks 17 to 20 and weeks 21 to 24
(May/June), an elevated incidence through the summer
months (weeks 21–36) that declines between weeks 37 and
48 (September to November) to the baseline level of inci-
dence seen in weeks 17–20 (Figure 2). Incidence appeared
in increase during the Christmas holiday period (weeks
49–52); this increase was sustained in the rural area until
week 8 (February). With the exception of one 4-week peri-
od (weeks 25–28), the monthly incidence of campylobac-
teriosis reported was higher in the rural area, but this
finding was only statistically significant during weeks
29–32 in 2003 and weeks 1–8 in 2004.
Sequence Typing of Isolates
Of 493 cases reported, 388 (79%) laboratory specimens
were obtained for typing. A proportion of the other cases
may not have been identified at the point of diagnosis as
study isolates because incomplete demographic informa-
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mitted for typing, 30 were C. coli, and 32 did not yield a
culture, which left 326 isolates (66% of reported cases) of
C. jejuni typed. From these isolates, 93 distinct MLST
sequence types of C. jejuni were identified and assigned to
21 clonal complexes, with 20 remaining unassigned until
further identification of types enables the designation of
new complexes. The most common clonal complex isolat-
ed was ST-21 (102 cases, 28.7% of all typed cases, includ-
ing C. jejuni and C. coli), and this complex was almost 3
times more common than the next complex ST-45 (35
cases, 9.8% of all typed cases) (Table 1). Almost 10% of
typed cases were unassigned to clonal complexes at time
of writing.
Geographic Distribution of Sequence Types
The geographic distribution of clonal complexes across
the study area varied. Of the 10 most commonly reported
clonal complexes (including ones not yet assigned), sever-
al were reported with higher incidence in the rural area,
although greater numbers are required to give sufficient
power to test the significance of these differences in many
groups (Table 2). The greatest variation was seen among
cases with clonal complexes ST-45 (incidence ratio [IR]
3.53, 95% CI 1.71–7.51) and ST-206 (IR = 1.88, 95%CI
0.65–5.30), although ST-45 was the only complex with a
significantly (p<0.001) higher incidence in the rural area.
Although not sequence typed, the incidence of C. coli (IR
2.69, 95%CI 1.23–5.95) was also significantly higher in
the rural area (p<0.01).
Temporal Distribution of Sequence Types
Temporal distribution of different clonal complexes in
each of the study areas also varied through the first year of
the study. Cases of clonal complex ST-45 were most often
reported in the rural area during weeks 25–28, although
cases were reported continuously throughout the summer
months (weeks 21–40, May to September, Figure 3). The
proportion of cases reported in weeks 25 to 28 that were
typed ST-45 was significantly higher that reported in the
annual rural dataset (proportion difference 0.188, exact
mid-p = 0.038) (data not shown). In the suburban area,
clonal complex ST-45 was most often reported during
weeks 21–28 (May to July), and the temporal distribution
appeared reduced. The only period in which the difference
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Figure 2. Seasonality of human cases of campylobacteriosis
reported in the first 12 months of the study period in patients resid-
ing in Fylde and Wyre (rural) and Salford and Trafford (suburban).
To allow comparison between the areas, the number of cases
reported to the North West Health Protection Agency surveillance
system during 4-week intervals were converted to incidence by
using estimates of the annual population for each local authority.
The periods at which the incidence differed with marginal statisti-
cal significance are indicated with an asterisk: weeks 29–32, inci-
dence ratio (IR) 1.79, 95% confidence intervals (CI) 0.98–3.22
(p = 0.05); weeks 1-4, IR 2.20, 95% CI 0.98–4.88 (p = 0.04);
weeks 5-8, IR 2.36, 95% CI 1.04–5.33 (p = 0.02).in ST-45 incidence between the areas approached signifi-
cance was weeks 25–28 (IR 3.3, 95% CI 0.9–13.17, p =
0.052) (data not shown). Clonal complex ST-45 was not
reported before week 21 in either area.
Cases of clonal complex ST-21 were reported more or
less throughout the 12-month period in both areas, but the
incidence fluctuated far less in the suburban area. Almost
50% of the cases reported in the suburban area in weeks 49
to 52 were clonal complex ST-21 compared with 30% in
the annual suburban dataset, but this difference was not
significant (proportion difference 0.176, exact mid-p =
0.113) (data not shown).
Clonal complex ST-206 was most often reported in the
rural area in weeks 25 to 28, and more remarkably in
weeks 41 to 44, when the proportion of cases typed as ST-
206 was significantly higher than in the annual dataset
(proportion difference 0.367, exact mid-p = 0.006) (data
not shown). Cases of clonal complex ST-206 were consis-
tently reported from weeks 25 through 44 (June to
October) in the suburban area, but the proportion of ST-
206 cases in weeks 37 to 40 was significantly higher than
in the annual dataset (proportion difference 0.101, exact
mid-p = 0.035).
Age Distribution of Sequence Types
Analysis of age-specific incidence by clonal complex
was hampered by low numbers of cases; only data for the
6 most commonly reported complexes are shown
(Table 3). Overall, the higher incidence of campylobacte-
riosis described in the rural area was also evident in each
of the age bands analyzed, although the difference in 0- to
14-year-old patients was only marginally significant (IR
1.72, 95% CI 0.91–3.18). Among cases in the most com-
monly reported clonal complex, ST-21, incidence among
younger case-patients (0- to 14-year-olds) was higher in
the suburban area, but for all other age groups, the inci-
dence was higher in the rural area. None of these differ-
ences were statistically significant. The only significant
difference was a higher incidence of ST-45 among those
>55 years of age in the rural area compared with those >55
years in the suburban area.
Discussion
We described some characteristics of human infection
with Campylobacter in 2 environmentally distinct areas of
NW England and some preliminary results of a study that
used MLST to better define the epidemiology of campy-
lobacteriosis within a distinct population. MLST identified
possible variations in the epidemiology of campylobacte-
riosis between populations. However, our sample sizes are
small, and the role of chance in the associations described
cannot be excluded without further analysis of a larger
dataset.
The seasonality of incidence in the 2 study areas is
broadly similar to that previously described (3,6) with a
sharp rise in cases around weeks 21 to 24 (May and June)
that is sustained through the summer months. Throughout
the first year of the study, incidence was higher in the rural
area of Fylde and Wyre than in the suburban area of
Salford and Trafford; this difference was most significant
in the first 8 weeks of 2004. This difference in incidence
was seen for all analyzed age groups, although it was not
statistically significant among 0- to 14-year-olds. These
observations may indicate increased exposure of the more
rural population to sources of Campylobacter and true dif-
ferences in distribution season between the 2 areas, per-
haps indicating distinct transmission routes. However, a
variety of other factors likely influenced these observa-
tions, including differences in healthcare-seeking behavior
between the populations and differences in frequency of
travel abroad. Although some adjustments have been made
for the underlying population structure of each study area
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Figure 3. Seasonal distribution of multilocus sequence typing
clonal complex in human cases of campylobacteriosis reported in
the first 12 months of the study period, by residence in A) Fylde
and Wyre (rural) and B) Salford and Trafford (suburban). The num-
ber of typed isolates reported during 4-week intervals was convert-
ed to incidence by using annual population estimates. The 8 most
commonly reported complexes are distinguished, with cases from
all other complexes presented as "other." The incidence of "all
cases reported" (typed and untyped) is presented for reference
(solid line). (the use of age-specific 4-weekly incidence), estimates of
population do not take into account the seasonal movement
of persons, such as students (Salford has a large student
population) and age-related travel (31,32). For instance,
the winter rise in incidence in the rural setting may be due,
in part, to winter vacations taken by those with the flexibil-
ity and finances to travel abroad out of season (generally
the older generation, who are also more represented in the
rural area of this study). The exclusion of travel-related
cases will be key in further exploring some of these trends,
and matching more detailed epidemiologic information
from case questionnaires will facilitate this as the study
progresses. Subsequent years of data analysis will also
clarify any true differences in incidence between the pop-
ulations.
Sequence typing isolates collected throughout the first
12 months of the study showed a wide range of identified
types, with many represented only by single cases and rel-
atively few identified in significant numbers. Several new
types were described in this study and await assignment to
clonal complexes. Almost 30% of typed isolates from the
study area align with the largest clonal complex so far
defined, complex ST-21 (23,30), and previously reported
isolates from this clonal complex originate from a wide
variety of sources other than human cases, including cattle,
chicken, milk, sand, and water (23). Most cases arising
from a large waterborne outbreak of campylobacteriosis in
Walkerton, Ontario, that originated from infected cattle
(33) were later identified as clonal complex ST-21 (34),
which suggests that this clonal complex can be associated
with environmental and foodborne transmission. Study of
a farm ecosystem in NW England demonstrated that most
clonal complex ST-21 isolates came from livestock, espe-
cially cattle (27). Isolates of clonal complex ST-21 have
also been described in cloacal and excreta samples from
broiler chickens (35) and from a variety of farmyard iso-
lates, including sheep and wild birds (36).
Isolates from the next most represented clonal complex
in the study area, complex ST-45, have previously been
reported largely from humans and chicken (23,37) and
were almost exclusively reported in broiler chicken and
turkey chicks in a study sampling various livestock and
wild birds in NW England (36). However, complex ST-45
was more frequently identified in wildlife than in livestock
Campylobacter MLST in Humans, Northwest England
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ecosystem studied did not include poultry).
Initial data from this current study suggest that ST-45
complex is more frequently identified in the rural compo-
nent of the study population than in the metropolitan com-
ponent, and particularly in those >55 years of age. This
finding raises the possibility that this complex may be
associated with an environmental transmission pathway, a
specific set of behavioral traits, or both. This hypothesis is
supported by the identification of this clonal complex in
wildlife isolates of Campylobacter (27), which suggests a
widespread distribution maintained in the environment.
Cases of C. coli in this study have a similar distribution,
and in previous studies this species has been the most dom-
inant one isolated from surface waters (20,38). The season-
al clustering of ST-45 complex human isolates (compared
with ST-21 complex) in summer months in the study pop-
ulations may also indicate an environmental source.
However, seasonal carriage rates in broiler flocks in other
north European settings (10,11) correlate with the season-
ality of ST-45 complex in this population, in which infec-
tion of beef cattle (13) correlates more closely to the
seasonality of ST-21 complex. Given the apparent host
preferences (not exclusively) of these 2 complexes, the
seasonality of human complexes in this study may only
reflect Campylobacter distribution in food animals rather
than a common environmental source, as suggested by pre-
vious studies (2,7,8).
No single sequence type was associated with the late
spring seasonal rise in human campylobacteriosis, a find-
ing consistent with that of a previous study in England that
used serotyping (26). However, we have shown complex
ST-45 to be significantly more prevalent during summer
months in rural than in suburban areas. In addition, some
evidence exists that a Christmas rise in infection in the
suburban population may in part be mediated by cases of
ST-21. Eating out at a restaurant is a recognized risk factor
for campylobacteriosis (32,39), and the Christmas season
involves a variety of public as well as private parties in the
United Kingdom. Identifying specific sequence types asso-
ciated with such seasonal activity may help clarify the role
of subpopulations of Campylobacter in human epidemiol-
ogy. Some evidence also suggests that MLSTis able to dis-
tinguish temporal clusters of campylobacteriosis such as
for ST-206, which is significantly overrepresented in
weeks 41 to 44 in the rural area.
As this 3-year study progresses, we will match MLST
complexes with common epidemiologic exposures
through the use of case questionnaire data. The ease of use
of the technique and its repeatability in a variety of labora-
tories are distinct advantages, and the increased use of
MLST will enable valuable interlaboratory comparisons of
types from similar population-based studies. We have
demonstrated the ability to improve linking of apparently
sporadic cases encountered in routine surveillance by
assigning isolates to sequence type complexes. We believe
that MLST will be a valuable tool in testing the signifi-
cance of suspected epidemiologic exposures in human
campylobacteriosis and thus support improved surveil-
lance and development of effective interventions. 
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